Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up

Conditions:   Schizophrenia;   Psychotic Disorders;   Psychosis Interventions:   Drug: Aripiprazole;   Drug: Risperidone Sponsors:   Fundación Marques de Valdecilla;   Centro de Investigación Biomédica en Red de Salud Mental;   Instituto de Investigación Marqués de Valdecilla Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials